Aureus Asset Management, LLC Abbott Laboratories Transaction History

Aureus Asset Management, LLC

$1.51 Billion
Q3 2024

A detailed history of Aureus Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Aureus Asset Management, LLC holds 269,531 shares of ABT stock, worth $34.5 Million. This represents 2.03% of its overall portfolio holdings.

Number of Shares

269,531

Previous 62,138 333.76%

Holding current value

$34.5 Million

Previous $6.46 Million 375.98%

% of portfolio

2.03%

Previous 0.45%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $20.8 Million - $24.5 Million	207,393 Added 333.76%	269,531 $30.7 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $430,721 - $480,793	-4,276 Reduced 6.44%	62,138 $6.46 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $258,795 - $285,828	2,363 Added 3.69%	66,414 $7.55 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $196,253 - $240,230	-2,176 Reduced 3.29%	64,051 $7.05 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $297,193 - $356,582	-3,111 Reduced 4.49%	66,227 $6.41 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $85,763 - $95,558	851 Added 1.24%	69,338 $7.56 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $272,854 - $321,166	-2,817 Reduced 3.95%	68,487 $6.93 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $66,827 - $78,398	703 Added 1.0%	71,304 $7.83 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $831,652 - $962,897	8,595 Added 13.86%	70,601 $6.83 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $1.1 Million - $1.33 Million	10,817 Added 21.13%	62,006 $6.74 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $150,620 - $183,671	1,321 Added 2.65%	51,189 $6.06 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $346,243 - $423,955	2,997 Added 6.39%	49,868 $7.02 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $191,672 - $212,045	1,643 Added 3.63%	46,871 $5.54 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $502,714 - $591,766	4,752 Added 11.74%	45,228 $5.24 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $184,701 - $217,606	1,697 Added 4.38%	40,476 $4.85 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $76,440 - $83,297	-728 Reduced 1.84%	38,779 $4.25 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $133,794 - $162,483	1,460 Added 3.84%	39,507 $4.3 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $259,036 - $331,534	3,383 Added 9.76%	38,047 $3.48 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $71,300 - $104,261	1,135 Added 3.39%	34,664 $2.74 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $120,434 - $134,071	1,534 Added 4.79%	33,529 $2.91 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $46,566 - $50,493	569 Added 1.81%	31,995 $2.68 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $46,861 - $54,655	643 Added 2.09%	31,426 $2.64 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $52,446 - $63,407	792 Added 2.64%	30,783 $2.46 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $45,957 - $52,063	701 Added 2.39%	29,991 $2.17 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $12,283 - $14,818	202 Added 0.69%	29,290 $2.15 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $80,482 - $88,828	-1,398 Reduced 4.59%	29,088 $1.77 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $123,175 - $139,264	2,189 Added 7.74%	30,486 $1.83 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $74,990 - $80,285	1,397 Added 5.19%	28,297 $1.62 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $1.29 Million - $1.44 Million	26,900	26,900 $1.44 Million

Others Institutions Holding ABT

# of Institutions

3,208

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aureus Asset Management, LLC with notifications on news.

Account

Aureus Asset Management, LLC Abbott Laboratories Transaction History